Outcomes of Urinary Tract Infection Management by Pharmacists

CompletedOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

June 16, 2017

Primary Completion Date

April 27, 2018

Study Completion Date

April 27, 2018

Conditions
Urinary Tract Infections
Interventions
OTHER

Advanced care

The pharmacist will assess for symptoms of urinary tract infection and, for patients in Arm 1, prescribe antibacterials when appropriate. For patients in Arm 2, pharmacists will ensure optimal therapy and adapt or perform therapeutic substitution when appropriate (or work with the patient to discontinue therapy or just put the prescription on file in instances where the patient is assessed to have asymptomatic bacteriuria for which treatment is inappropriate).

Trial Locations (1)

T6G 2S2

EPICORE Centre, University of Alberta, Edmonton

All Listed Sponsors
collaborator

Horizon Health Network

OTHER

collaborator

New Brunswick Pharmacists' Association

UNKNOWN

collaborator

Loblaw Companies Ltd.

UNKNOWN

collaborator

Pharmasave Drugs (Atlantic) Ltd.

UNKNOWN

collaborator

Alberta Pharmacists Association

UNKNOWN

collaborator

The Jean Coutu Group (PJC) Inc.

UNKNOWN

lead

University of Alberta

OTHER

NCT03184818 - Outcomes of Urinary Tract Infection Management by Pharmacists | Biotech Hunter | Biotech Hunter